Muller-Nordhorn, Jacqueline; Willich, Stefan N. - In: Disease Management and Health Outcomes 13 (2005) 2, pp. 73-82
A number of large randomized controlled trials (RCTs) have documented the effectiveness of HMG-CoA reductase inhibitor (`statin') therapy for both primary and secondary prevention of coronary heart disease. Current international guidelines, therefore, recommend the use of statin therapy in...